DG Comp issues fresh pay-for-delay charge

Sonya Lalli

17 July 2017

DG Comp issues fresh pay-for-delay charge

iStock.com/Savushkin

The EU’s competition watchdog has accused drugmaker Teva and subsidiary Cephalon – a former rival – of signing an illegal patent settlement in which Teva agreed to delay the entry of a generic sleep disorder drug.